| Education and training |
|
| 2010-2016 |
Resident and Fellow |
Tianjin the First Center Hospital
Ophthalmology |
| 2012-2014 |
Fellow and visiting scholar |
Michigan University Kellogg Eye Center |
| 2016-present |
Attending and Associate professor |
Tianjin Medical University Eye Hospital
Orbital Disease and Oculoplastic Surgery |
| |
|
|
| |
|
| Professional memberships |
the committee membership of Orbital Disease and Oculoplastic Surgery Group of Chinese Ophthalmologist Association(COA) |
| |
|
|
| Selected publications |
|
| 2019 |
European review for medical and pharmacological sciences. |
Xiaoming Huang, Shuangshuang Shi, Tianming Jian, Dongrun Tang, Tong Wu*, Fengyuan Sun*. LncRNA PVT1 Knockdown Affects Proliferation and Apoptosis of Uveal Melanoma Cells by Inhibiting EZH2. European review for medical and pharmacological sciences. 2019,23:2880-2887. |
| |
|
|
| 2017 |
Gene Therapy |
Tong Wu，Li-Na Wang ，Dong-Run Tang，Feng-Yuan Sun* , SOST silencing promotes proliferation, invasion and migration of human retinoblastoma HXO-RB44cells by activating Wnt/β-catenin signaling pathway；Gene Therapy, 2017 Jul;24(7):399-407. |
| |
|
|
| 2017 |
Can JPhysiol Pharmacol |
Wu T, Tang DR, Zhao L, Sun FY. Poly (ADP-Ribose) Polymerase-1 (PARP-1) in Chinese patients with Graves Disease and Graves Ophthalmopathy；Can JPhysiol Pharmacol；2017 Jan 29. doi: 10.1139/cjpp-2016-0332. |
| |
|
|
| 2016 |
Mol Med Rep |
Wu T, Sun L, Wu Y, Xiang R, Li Y, Rong W, Sun F, Wang N Prognostic Value of Legumain in Uveal Melanoma；Mol Med Rep. 2016Mar;13(3):2377-84. |
| |
|
|
| 2016 |
THYROID |
Wu T, Mester T,Gupta S,Sun F,Smith TJ,Douglas RS Thyrotropin and CD40L Stimulate Interleukin-12 Expression in Fibrocytes: Implications for Pathogenesis of Thyroid-Associated Ophthalmopathy; THYROID; 2016 Dec;26(12):1768-1777 |
| Publications on Pubmed links |
https://www.ncbi.nlm.nih.gov/pubmed?term=(((
Tong%20Wu%5BAuthor%5D))%20AND%20Tianjin%20Medical%20University%20Eye) |
